RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #NephJC 👉🏼 http…
The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #NephJC 👉🏼 https://t.co/RRSkHepKGe https://t.co/1iyRDBN1Js
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
RT @edgarvlermamd: The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀…
The role of plasma exchange in treating post-transplant FSGS ca. 2016 from @BioMedCentral #Nephpearls #Nephmadness 2️⃣🏀1️⃣9️⃣ #PLEXRegion 👉🏼 https://t.co/RRSkHe89OG https://t.co/6s3i8ynHrC
RT @caioqualunque: PEX: rescue treatment in #FSGS recurrence after transplantation or rarely in non-responders: up to 54% of patients have…
PEX: rescue treatment in #FSGS recurrence after transplantation or rarely in non-responders: up to 54% of patients have prolonged decrease in proteinuria and renal function stabilization. #GlomPearls https://t.co/m6PdqHzAxI
Schiffer: overall remission rate was 71% for post-transplant FSGS treated with PEx, n=423 #eraedta18 https://t.co/im1fPVNMZb